See more : EFG International AG (EFGN.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Bio Science Animal Health Public Company Limited (BIS.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bio Science Animal Health Public Company Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Poema Global Holdings Corp. (PPGH) Income Statement Analysis – Financial Results
- Energica Motor Company S.p.A. (EICAF) Income Statement Analysis – Financial Results
- Vitec Software Group AB (publ) (VIT-B.ST) Income Statement Analysis – Financial Results
- Broadscale Acquisition Corp. (SCLEW) Income Statement Analysis – Financial Results
- Thunder Bridge Capital Partners IV Inc. (THCPW) Income Statement Analysis – Financial Results
Bio Science Animal Health Public Company Limited (BIS.BK)
About Bio Science Animal Health Public Company Limited
Bio Science Animal Health Public Company Limited trades in animal pharmaceutical, feed additive, and raw material products for livestock, aquaculture, and pet markets in Thailand. It offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, and water-soluble products, as well as vaccines; feed additives, disinfectants, and amino acids; medical supplies and diagnostic tools; and animal health and nutrition products. The company was incorporated in 2004 and is based in Nonthaburi, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.41B | 2.19B | 1.97B | 1.76B | 371.82M | 352.71M | 435.63M |
| Cost of Revenue | 2.08B | 1.88B | 1.63B | 1.44B | 269.55M | 264.66M | 335.96M |
| Gross Profit | 332.80M | 316.95M | 346.87M | 318.68M | 102.27M | 88.05M | 99.68M |
| Gross Profit Ratio | 13.80% | 14.44% | 17.57% | 18.10% | 27.50% | 24.96% | 22.88% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 109.09M | 96.70M | 106.81M | 91.18M | 23.63M | 23.77M | 23.36M |
| Selling & Marketing | 169.95M | 163.48M | 155.56M | 151.62M | 60.34M | 66.41M | 73.50M |
| SG&A | 279.03M | 260.17M | 262.37M | 242.79M | 83.98M | 90.17M | 96.86M |
| Other Expenses | -14.52M | -25.26M | -10.99M | -2.59M | -9.15M | -16.46M | -23.72M |
| Operating Expenses | 264.51M | 234.91M | 251.38M | 240.21M | 74.82M | 73.72M | 73.14M |
| Cost & Expenses | 2.34B | 2.11B | 1.88B | 1.68B | 344.38M | 338.38M | 409.10M |
| Interest Income | 0.00 | 6.27M | 319.41K | 1.14M | 3.51M | 0.00 | 0.00 |
| Interest Expense | 1.89M | 6.27M | 9.94M | 9.07M | 5.02M | 4.41M | 4.34M |
| Depreciation & Amortization | 16.46M | 15.72M | 17.37M | 14.58M | 18.40M | 7.80M | 7.87M |
| EBITDA | 84.74M | 97.75M | 113.61M | 93.42M | 45.84M | 22.13M | 26.53M |
| EBITDA Ratio | 3.51% | 4.45% | 5.75% | 5.54% | 12.33% | 4.06% | 6.09% |
| Operating Income | 68.29M | 82.03M | 96.24M | 78.84M | 27.44M | 14.33M | 26.53M |
| Operating Income Ratio | 2.83% | 3.74% | 4.87% | 4.48% | 7.38% | 4.06% | 6.09% |
| Total Other Income/Expenses | -1.89M | -6.27M | -9.65M | -5.70M | -18.02M | 2.37M | -4.34M |
| Income Before Tax | 66.40M | 75.77M | 86.60M | 73.14M | 41.76M | 9.92M | 22.19M |
| Income Before Tax Ratio | 2.75% | 3.45% | 4.39% | 4.15% | 11.23% | 2.81% | 5.09% |
| Income Tax Expense | 13.52M | 16.09M | 17.97M | 18.70M | 5.19M | 3.09M | 3.07M |
| Net Income | 50.71M | 55.92M | 72.40M | 54.45M | 36.57M | 6.83M | 19.12M |
| Net Income Ratio | 2.10% | 2.55% | 3.67% | 3.09% | 9.84% | 1.94% | 4.39% |
| EPS | 0.16 | 0.20 | 0.33 | 0.66 | 0.31 | 0.02 | 0.06 |
| EPS Diluted | 0.16 | 0.20 | 0.33 | 0.66 | 0.31 | 0.02 | 0.06 |
| Weighted Avg Shares Out | 314.00M | 283.61M | 220.00M | 94.00M | 94.00M | 314.00M | 314.00M |
| Weighted Avg Shares Out (Dil) | 314.00M | 283.61M | 220.00M | 94.00M | 94.00M | 314.00M | 314.00M |
Source: https://incomestatements.info
Category: Stock Reports